Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron C Shaver

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Leukemia & Lymphoma|June 25, 2019
Myelodysplastic/myeloproliferative neoplasm with eosinophilia as a manifestation of Li Fraumeni SyndromeScott A Turner, Aaron C Shaver, Alexandra E Kovach, et al.
Kidney Medicine|October 22, 2020
Lymphoma and the Kidney: A Kidney Biopsy Teaching CaseVincenzo L'Imperio, Mattia Rossi, Afu Abdul, et al.
American Journal of Clinical Pathology|March 15, 2018
Limited Utility of Fluorescence In Situ Hybridization for Recurrent Abnormalities in Acute Myeloid Leukemia at Diagnosis and Follow-upFerrin C Wheeler, Annette S Kim, Claudio A Mosse, et al.
American Journal of Hematology|April 6, 2024
Distinct bone marrow findings associated with a noncanonical UBA1 variant in VEXAS syndromeDevin R Allison, Bhagirathbhai Dholaria, Ashwin Kishtagari, et al.
Genetics|October 26, 2002
Fitness evolution and the rise of mutator alleles in experimental Escherichia coli populationsAaron C Shaver, Peter G Dombrowski, Joseph Y Sweeney, et al.
Archives of Pathology & Laboratory Medicine|July 31, 2014
Transformation of small B-cell lymphoma into large cell CD30⁺, CD4⁺, Epstein-Barr virus-negative lymphomaAaron C Shaver, Ly Ma, Cindy Vnencak-Jones, et al.
American Journal of Clinical Pathology|October 23, 2016
Data-Driven Iterative Refinement of Bone Marrow Testing Protocols Leads to Progressive Improvement in Cytogenetic and Molecular Test UtilizationAdam C Seegmiller, Annette S Kim, Claudio A Mosse, et al.
American Journal of Hematology|September 15, 2022
Secondary-type mutations do not impact prognosis in acute myelogenous leukemia AML with mutated NPM1Martha F Wright, Olga Pozdnyakova, Robert P Hasserjian, et al.
Leukemia Research|January 9, 2018
Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemiaStephen A Strickland, Aaron C Shaver, Michael Byrne, et al.
Cytometry. Part B, Clinical Cytometry|May 6, 2017
A QA Program for MRD Testing Demonstrates That Systematic Education Can Reduce Discordance Among Experienced InterpretersMichael Keeney, Brent L Wood, Benjamin D Hedley, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|June 25, 2019
Myelodysplastic/myeloproliferative neoplasm with eosinophilia as a manifestation of Li Fraumeni SyndromeScott A Turner, Aaron C Shaver, Alexandra E Kovach, et al.
Kidney Medicine|October 22, 2020
Lymphoma and the Kidney: A Kidney Biopsy Teaching CaseVincenzo L'Imperio, Mattia Rossi, Afu Abdul, et al.
American Journal of Clinical Pathology|March 15, 2018
Limited Utility of Fluorescence In Situ Hybridization for Recurrent Abnormalities in Acute Myeloid Leukemia at Diagnosis and Follow-upFerrin C Wheeler, Annette S Kim, Claudio A Mosse, et al.
American Journal of Hematology|April 6, 2024
Distinct bone marrow findings associated with a noncanonical UBA1 variant in VEXAS syndromeDevin R Allison, Bhagirathbhai Dholaria, Ashwin Kishtagari, et al.
Genetics|October 26, 2002
Fitness evolution and the rise of mutator alleles in experimental Escherichia coli populationsAaron C Shaver, Peter G Dombrowski, Joseph Y Sweeney, et al.
Archives of Pathology & Laboratory Medicine|July 31, 2014
Transformation of small B-cell lymphoma into large cell CD30⁺, CD4⁺, Epstein-Barr virus-negative lymphomaAaron C Shaver, Ly Ma, Cindy Vnencak-Jones, et al.
American Journal of Clinical Pathology|October 23, 2016
Data-Driven Iterative Refinement of Bone Marrow Testing Protocols Leads to Progressive Improvement in Cytogenetic and Molecular Test UtilizationAdam C Seegmiller, Annette S Kim, Claudio A Mosse, et al.
American Journal of Hematology|September 15, 2022
Secondary-type mutations do not impact prognosis in acute myelogenous leukemia AML with mutated NPM1Martha F Wright, Olga Pozdnyakova, Robert P Hasserjian, et al.
Leukemia Research|January 9, 2018
Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemiaStephen A Strickland, Aaron C Shaver, Michael Byrne, et al.
Cytometry. Part B, Clinical Cytometry|May 6, 2017
A QA Program for MRD Testing Demonstrates That Systematic Education Can Reduce Discordance Among Experienced InterpretersMichael Keeney, Brent L Wood, Benjamin D Hedley, et al.
Pageof 3